EBITDA of USD 472m (-5% vs. ARCe, -7% vs. Cons.)EPS of USD 0.90/sh (-2% vs. ARCe) and H1 DPS of USD 1.10/sh (+1% vs. ARCe, +6% vs. Cons.)Reiterates 2025 outlook; We expect only minor estimate changes after todayNeutral report; Expect the stock to trade in line with the market
